Direct access to a registered nurse, no appointment needed
Currently, only Novo Nordisk is authorized by the FDA to manufacture semaglutide and there is no generic available
Gentle dose increases reduce the risk of retinopathy worsening Your body adjusts more comfortably to metabolic changes over time Slower improvement may delay results slightly but protects long-term vision Patience during the early weeks of treatment pays off in the months ahead Do not delay needed diabetes control, instead coordinate dosing and monitoring so improvements occur at a pace your eyes can tolerate We encourage you to pay attention to your vision between scheduled exams and report any changes promptly
Trends in Endocrinology and Metabolism: TEM, 31 (6), 410421
However, endogenous GLP-1 has an extremely short half-life due to rapid degradation by dipeptidyl peptidase-4 and renal clearance
By consistently reviewing blood test results, you or your doctor can detect patterns or abnormalities that may indicate the onset of potential side effects such as pancreatitis or changes in thyroid function